Just last week, the agency rejected Moderna’s initial application, citing flaws in the company’s research design.

Moderna announced the change Wednesday, about a week after revealing that the FDA’s vaccine chief was refusing to review the new vaccine, made with Nobel Prize-winning mRNA technology.

Gov. Josh Shapiro is deploying additional resources to support Pennsylvania poultry farmers amid a significant avian flu outbreak, marking the state's hardest hit since the 1980s.

The FDA has accepted Moderna’s revised approach seeking full approval for the shot for adults aged between 50 and 64, and accelerated approval for those aged 65 and above, the company said, adding ...

By Mariam Sunny and Michael Erman Feb 18 (Reuters) - Moderna said on Wednesday the U.S. Food and Drug Administration changed course and will review an amended application for its new flu vaccine, a ...

The Food and Drug Administration's about-face comes a little more than a week after the agency refused to consider the ...

Moderna held further discussions with regulators and announced that the agency would accept the company’s application for approval of its flu vaccine that uses mRNA technology.

The NJ DEP has received over 1,100 calls for dead wild birds. Harsh winter conditions and possible bird flu are suspected ...

The US Food and Drug Administration will now review Moderna’s new, messenger RNA–based flu vaccine after all, reversing course on a decision that rocked the biopharmaceutical industry last week.

With the reversal from the FDA, Moderna said it is aiming to make the vaccine available for the 2026-27 flu season.

From a potential new flu vaccine to a groundbreaking surgical first and critical health reminders, here's today's essential health news.